Related Experiment Videos
Circulating lupus anticoagulant in a surgical temporomandibular joint patient. Report of a case
1Division of Oral and Maxillofacial Surgery, Allegheny General Hospital, Pittsburgh, Pa.
Oral Surgery, Oral Medicine, and Oral Pathology
|April 1, 1988
Abstract:
The lupus anticoagulant is a unique inhibitor of hemostasis. Its occurrence in patients with systemic lupus erythematosus reportedly varies from 5% to 50%. The inhibitor is endogenously produced and occurs in a diverse number of clinical states. The present case report reviews an inadvertent discovery of circulating lupus anticoagulant in a patient scheduled for surgery of the temporomandibular joint.